June 13th 2025
An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers played their part.
Study Highlights PBMs’ Role in Drug Prices
September 22nd 2023An analysis by 3 Axis Advisors has found that there is a large variability in pharmacy reimbursement of prescription drugs depending on PBM contracts with insurers. This creates a system with huge inconsistencies on the prices of both generics and branded products.